The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...

Neuralink’s Blindsight device is designed to enable individuals who are completely blind, including those who have lost both eyes or their optic nerve, to perceive visual images. It even aims to ...